Results 11 to 20 of about 6,160,477 (183)

Metastatic Basal Cell Carcinoma: A Biological Continuum of Basal Cell Carcinoma? [PDF]

open access: yesCase Reports in Dermatological Medicine, 2012
Basal cell carcinoma (BCC) accounts for 80% of all nonmelanoma skin cancers. Its metastasis is extremely rare, ranging between 0.0028 and 0.55 of all BCC cases. The usual metastasis to lymph nodes, lungs, bones, or skin is from the primary tumor situated
Karaninder S. Mehta   +9 more
doaj   +6 more sources

Metastatic basal cell carcinoma

open access: yesJournal of Radiation and Cancer Research, 2021
Basal cell carcinoma (BCC) is the most frequent, slow–growing, and potentially locally aggressive neoplasm of skin that rarely metastasizes. Incidence of BCC is high, but metastatic BCC is extremely rare.
Isha Shah, Aastha Shah, U Suryanarayan
doaj   +5 more sources

Metastatic basal cell carcinoma to the lungs: Case report and review of literature

open access: yesIndian Dermatology Online Journal, 2014
Basal cell carcinoma is the most common form of skin cancer and it rarely metastasizes. The prevalence of metastatic basal cell carcinoma (MBCC) varies between 0.0028% and 0.55% of all cases. Over 250 MBCC have been reported in the literature. We present
Henry Benson Nongrum   +3 more
doaj   +2 more sources

Metastatic basal cell carcinoma

open access: yesAmerican Journal of Otolaryngology, 2011
The purpose of this study is to review our series of metastatic basal cell carcinomas of the head and neck.A retrospective review was conducted for this study.All cases of documented metastatic basal cell carcinomas arising from a primary within the head and neck region and presenting for treatment to one of the authors (Y.D.) were included in this ...
Yadranko, Ducic, Diego E, Marra
core   +5 more sources

Investigational agents in metastatic basal cell carcinoma: focus on vismodegib

open access: yesJournal of Experimental Pharmacology, 2012
Nicolas Batty,1 Ellen Kossoff,2 Grace K Dy11Department of Medicine, Roswell Park Cancer Center, Buffalo, NY, USA; 2Department of Pharmacy, Roswell Park Cancer Center, Buffalo, NY, USAAbstract: Vismodegib (GDC-0449, 2-chloro-N-(4-chloro-3-(pyridin-2-yl ...
Batty N, Kossoff E, Dy GK
doaj   +1 more source

Metastatic Basal Cell Carcinoma: A Rare Manifestation of a Common Disease [PDF]

open access: yesCase Reports in Medicine, 2017
Introduction. Basal cell carcinoma (BCC) is considered the most common malignancy in Caucasians. It constituted about 80% of all nonmelanoma skin tumors and, despite its high prevalence, is an extremely rare occurrence of metastases, with incidence rates
Paola Piva de Freitas   +4 more
doaj   +2 more sources

Metastatic Basal Cell Carcinoma Accompanying Gorlin Syndrome [PDF]

open access: yesCase Reports in Oncological Medicine, 2014
Yeliz Bilir   +5 more
doaj   +2 more sources

Metastatic basal cell carcinoma with loss of p63 and mismatch repair proteins [PDF]

open access: yesJAAD Case Reports, 2017
Nathan M. Johnson, MS   +5 more
doaj   +2 more sources

Atypical Presentation of Metastatic Basal Cell Carcinoma

open access: yesSouthern Medical Journal, 2004
Basal cell carcinoma is an indolent, slow-growing tumor that rarely metastasizes. Approximately 70% of tumors occur in the head and neck regions. If a basal cell tumor metastasizes, it usually spreads to the regional lymph nodes first, followed by the lungs.
Colvett, Kyle T.   +2 more
openaire   +4 more sources

Metastatic Basal Cell Carcinoma. [PDF]

open access: yesAm J Clin Pathol, 2019
AbstractObjectivesDiagnosis of metastatic basal cell carcinoma (BCC) remains challenging, in part due to its rarity. With the advent of molecularly targeted therapies, recognition of this entity is more important than ever.MethodsWe identified 11 cases of metastatic BCC over a 13-year period.
Laga AC   +4 more
europepmc   +4 more sources

Home - About - Disclaimer - Privacy